Filing Details
- Accession Number:
- 0001192482-11-000046
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-03-03 19:38:11
- Reporting Period:
- 2011-03-01
- Filing Date:
- 2011-03-03
- Accepted Time:
- 2011-03-03 19:38:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1070336 | Achillion Pharmaceuticals Inc | ACHN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1497725 | Quaker Bioventures Ii Lp | C/O Quaker Bioventures Ii, L.p. 2929 Arch Street Philadelphia PA 19104 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2011-03-01 | 100,000 | $5.88 | 4,602,651 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2011-03-02 | 57,500 | $5.90 | 4,545,151 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2011-03-03 | 66,300 | $5.92 | 4,478,851 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Represents the weighted average sales price for price increments ranging from $5.80 to $6.08.
- The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- The securities are deemed to be beneficially owned by Quaker BioVentures II, L.P. and Quaker BioVentures Capital II, LLC. Quaker BioVentures Capital II, L.P. is the general partner of Quaker BioVentures II, L.P. Quaker BioVentures Capital II, LLC is the general partner of Quaker BioVentures Capital II, L.P.
- Represents the weighted average sales price for price increments ranging from $5.83 to $5.95.
- Represents the weighted average sales price for price increments ranging from $5.80 to $6.00.
Billionaire Hedge Funds
